CorVel Co. (NASDAQ:CRVL) Shares Purchased by Whittier Trust Co. of Nevada Inc.

Whittier Trust Co. of Nevada Inc. increased its stake in shares of CorVel Co. (NASDAQ:CRVL) by 200.0% in the 4th quarter, Holdings Channel.com reports. The firm owned 939 shares of the business services provider’s stock after purchasing an additional 626 shares during the period. Whittier Trust Co. of Nevada Inc.’s holdings in CorVel were worth $104,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently bought and sold shares of the company. Fifth Third Bancorp lifted its stake in shares of CorVel by 45.9% in the 4th quarter. Fifth Third Bancorp now owns 321 shares of the business services provider’s stock worth $36,000 after acquiring an additional 101 shares during the period. Jones Financial Companies Lllp acquired a new stake in shares of CorVel in the 4th quarter worth $37,000. US Bancorp DE lifted its stake in shares of CorVel by 225.4% in the 4th quarter. US Bancorp DE now owns 384 shares of the business services provider’s stock worth $43,000 after acquiring an additional 266 shares during the period. GAMMA Investing LLC lifted its stake in shares of CorVel by 175.2% in the 4th quarter. GAMMA Investing LLC now owns 432 shares of the business services provider’s stock worth $48,000 after acquiring an additional 275 shares during the period. Finally, Exchange Traded Concepts LLC lifted its stake in shares of CorVel by 216.7% in the 4th quarter. Exchange Traded Concepts LLC now owns 532 shares of the business services provider’s stock worth $59,000 after acquiring an additional 364 shares during the period. 51.36% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, Director Steven J. Hamerslag sold 10,000 shares of the business’s stock in a transaction dated Thursday, February 6th. The shares were sold at an average price of $123.48, for a total value of $1,234,800.00. Following the sale, the director now directly owns 314,000 shares in the company, valued at $38,772,720. The trade was a 3.09 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Jeffrey J. Michael sold 10,477 shares of the business’s stock in a transaction dated Thursday, February 20th. The stock was sold at an average price of $116.45, for a total transaction of $1,220,046.65. Following the completion of the sale, the director now owns 568,310 shares in the company, valued at $66,179,699.50. This represents a 1.81 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 32,200 shares of company stock worth $3,824,115 in the last 90 days. 47.57% of the stock is currently owned by corporate insiders.

CorVel Stock Performance

CRVL stock opened at $107.86 on Monday. The company has a fifty day moving average of $112.06 and a 200-day moving average of $114.27. The stock has a market capitalization of $5.54 billion, a PE ratio of 63.45 and a beta of 1.06. CorVel Co. has a one year low of $76.20 and a one year high of $128.61.

CorVel (NASDAQ:CRVL) last announced its quarterly earnings results on Tuesday, February 4th. The business services provider reported $0.46 earnings per share (EPS) for the quarter. CorVel had a net margin of 10.12% and a return on equity of 32.22%.

Analyst Ratings Changes

Separately, StockNews.com cut shares of CorVel from a “buy” rating to a “hold” rating in a research note on Thursday, March 13th.

CorVel Profile

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.